TNF and Other metabolic disease: The LXR-enhanced phagolytic activity of resKCs and decreased TNF-α production by recMφs are both beneficial for host protection against bacterial infections and TNF-α-mediated metabolic disease (diabetes, atherosclerosis, NASH, etc.).